<DOC>
	<DOCNO>NCT00137657</DOCNO>
	<brief_summary>At least three study sub-Saharan Africa demonstrate decrease morbidity mortality among HIV-infected adult take daily cotrimoxazole ( trimethoprim sulfamethoxazole ) [ CTX ] prophylaxis . Because demonstrated beneficial effect , high tolerability low cost CTX , United Nations Programme HIV/AIDS ( UNAIDS ) recommend HIV-infected person symptomatic HIV depress CD4 count receive daily CTX . The effect recommendation subsequent development antimicrobial resistance antifolates among important pathogen need evaluate . The investigator measure change prevalence marker antifolate resistance among P. falciparum , change prevalence CTX resistance among S. pneumoniae , E. coli HIV-infected individual receive CTX daily prophylaxis . In addition , investigator measure change prevalence naso-pharyngeal oro-pharyngeal carriage CTX resistant S. pneumoniae among child live household HIV-infected adult receive CTX daily prophylaxis .</brief_summary>
	<brief_title>Impact Cotrimoxazole Prophylaxis HIV-Infected Adults Antifolate Resistance</brief_title>
	<detailed_description>We conduct study Kisumu , Kenya HIV prevalence high malaria highly endemic . HIV infect uninfected adult assign receive daily CTX CD4 cell count &lt; 350 , daily multivitamin CD4 cell count &gt; = 350 client HIV negative . All client follow total 6 month . At specify schedule sick visit , client receive physical exam , blood smear , nasopharyngeal swabs stool sample rectal swab . Samples collect baseline follow-up use measure change CTX resistance among P. falciparum parasite , pneumococcus isolates , commensal E. coli .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Opportunistic Infections</mesh_term>
	<mesh_term>Folic Acid Antagonists</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<criteria>Clients present CRC HIV counsel test site Kisumu eligible study meet follow inclusion criterion : 15 year age older Able make followup visit ( i.e . plan leave Kisumu next 6 month , homebound ) Able understand give informed consent . Clients eligible study meet follow exclusion criterion : Known allergic reaction sulfa medication ( i.e . CTX , sulfadoxine pyrimethamine ) Women first trim pregnancy plan become pregnant next 6 month Clients take daily antibiotic treatment chronic illness ; prophylaxis , exclude tuberculosis treatment .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>HIV</keyword>
	<keyword>malaria</keyword>
	<keyword>E. Coli</keyword>
	<keyword>S. pneumoniae</keyword>
	<keyword>drug resistance</keyword>
	<keyword>antifolate</keyword>
	<keyword>opportunistic infection</keyword>
	<keyword>Africa</keyword>
	<keyword>Kenya</keyword>
	<keyword>East Africa</keyword>
</DOC>